Location: Home > Pharma China Web Edition
  • search
  • go
  • Feature Articles
  • 7/16/2024China's Health Supplements Market: Trends and Opportunities for Busine...
  • 7/16/2024Who Will Acquire Legend Bio for 13B to 15B USD? Could It Be J&J? (Drug...
  • 7/15/2024China's Once-booming Online Healthcare Sector Sees Its Vital Signs Sin...
  • 7/15/2024Will US Clinical Study Diversity Guidance Cloud Chinese Firms' Prospec...
  • 7/15/2024China Biopharma Tracker – H1/2024 (PharmaNJ)
  • 7/15/2024China's Fast-following Approach Positions It at the Forefront of the F...
  • 7/12/2024Prominence of Asia in Global Pharma Clinical Trials Rising Substantial...
  • 7/11/2024Political Change Around China Means Change for Pharma (The Medicine Ma...
  • 7/11/2024Biopharma Partnership Interest with China Remains High: LEK Survey
  • 7/10/2024House Speaker Mike Johnson Pledges Vote for BIOSECURE as China-targeti...
  • 7/9/2024China's Pharmaceutical Industry Bets Big on Small Nucleic Acid Drugs i...
  • 7/9/2024China's Supreme People's Court Clarifies Priority Examination Standard...
  • 7/2/2024What is the Current Landscape of Obesity Drug Development in China? (L...
  • 6/27/2024Industry Braces for Biosecure Act Impact (C&EN)
  • 6/26/2024On Efficiency of China's Drug-Related Patent Term Compensation System ...
  • 6/25/2024Leveraging Injunctive Relief in Pharmaceutical Patent Disputes in Chin...
  • 6/20/2024Cheaper Versions of Blockbuster Obesity Drugs Are Being Created in Ind...
  • 6/19/2024Big Changes to China's BMI System Expected at 3rd Plenum (Pekingnology...
  • 6/18/2024China Biopharma Tracker – May 2024 (PharmaDJ)
  • 6/14/2024In Depth: How China's Pricing Regime Penalizes Innovative Drugmakers (...
  • 6/4/2024China Biotech Podcast: Going Global Trends, Rare Disease Drug Developm...
  • 6/3/2024Western Companies Drive Chinese Biotech Licensing Deal Blitz (FT)
  • 5/31/2024Building Resilient Supply Chains in the Face of Tightening Chinese Ant...
  • 5/31/2024Manufacturing Inspections Down in China amid Arrest Fears and No Acces...
  • 5/30/2024U.S. Rethinks Timing of Biotech Crackdown, Easing Pressure on WuXi Fam...
  • 5/29/2024Caixin Explains: How China Is Overhauling Regulations on Genetic Resou...
  • 5/23/2024Hong Kong Emerges As Global Health Innovation Hub Under China New Plan...
  • 5/21/2024Chinese Biotechs Remain Optimistic About Cross-border Cooperations Des...
  • 5/21/2024With $5B in China Sales, AstraZeneca Doubles Down on Chinese Biopharma...
  • 5/21/2024China's Investigator Trials Accelerate Competitive CAR T Development (...
  • Page:1/7 Total number of articles:186: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group